Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-268,200
Closed -$1.95M 1464
2025
Q1
$1.95M Sell
268,200
-15,400
-5% -$135K 0.02% 590
2024
Q4
$2.22M Buy
283,600
+122,200
+76% +$1.01M 0.01% 632
2024
Q3
$1.19M Sell
161,400
-2,500
-2% -$21K 0.01% 739
2024
Q2
$1.31M Hold
163,900
0.01% 665
2024
Q1
$1.91M Buy
163,900
+1,500
+0.9% +$16.6K 0.02% 610
2023
Q4
$1.81M Buy
+162,400
New +$1.49M 0.01% 751
2023
Q2
Sell
-15,200
Closed -$231K 1778
2023
Q1
$231K Buy
+15,200
New +$198K ﹤0.01% 1312

Other funds holding ETNB

Jefferies Financial Group's ETNB Position: Q2 2025 in Review

Jefferies Financial Group sold out of 89bio (ETNB) in Q2 2025, closing a stake of 181,000 shares — an estimated $1.32M sold.

Jefferies Financial Group first reported a position in ETNB in Q1 2023 and held it in 8 quarters. The position peaked at $1.32M in Q1 2025. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

  • Jefferies Financial Group reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 181,000 89bio shares in Q2 2025, an estimated $1.32M.
  • Jefferies Financial Group first reported a position in 89bio in Q1 2023 and held it in 8 quarters.
  • Jefferies Financial Group's 89bio position peaked at $1.32M in Q1 2025.
  • 184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on Jefferies Financial Group's 13F filing for Q2 2025, filed 12 Aug 2025.